Penn Medicine Provider
Family Medicine
Kevin Kline, MD
He/Him
4.9
(537)
LGBTQ+ affirming provider
Additional provider information
Accepting new patients
Sees patients of all ages
Penn Family Medicine Pennsylvania Hospital

About me

  • Director of LGBTQ+ Health, Department of Family Medicine and Community Health
  • Medical Director for LGBTQ+ Health, Penn Medicine
  • Associate Professor of Clinical Family Medicine and Community Health

Education and training

  • Medical School: Saint Louis University - School of Medicine
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

538 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

July 2025
4.0
4.0
all right
July 2025
5.0
5.0
asked good questions. gave thoughtful responses
July 2025
5.0
5.0
he took his time and he was patient and he listened to what i had to say
July 2025
5.0
5.0
Dr. Kline gets 5 gold stars from me for being a great provider.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kline is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hodan R, Rodgers-Fouche L, Chittenden A, Dominguez-Valentin M, Ferriss J, Gima L, Hamnvik OR, Idos GE, Kline K, Koeller DR, Long JM, McKenna D, Muller C, Thoman M, Wintner A, Bedrick BS; Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer , Fam Cancer, 22(4): 2023,437-448